Venus Concept Inc. Files 8-K on Operations and Financials

TL;DR

Venus Concept filed an 8-K on Nov 13th covering Nov 10th events - check financials!

AI Summary

Venus Concept Inc. filed an 8-K on November 13, 2025, reporting on events that occurred on November 10, 2025. The filing pertains to results of operations, financial condition, and other events, including financial statements and exhibits. The company, formerly known as Restoration Robotics, Inc., is incorporated in Delaware and headquartered in Toronto, Ontario.

Why It Matters

This 8-K filing provides an update on Venus Concept Inc.'s operational and financial status, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting on operational and financial events, not indicating any immediate or significant new risks.

Key Players & Entities

• Venus Concept Inc. (company) — Registrant
• Restoration Robotics, Inc. (company) — Former company name
• November 10, 2025 (date) — Earliest event date
• November 13, 2025 (date) — Filing date

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value per share VERO The Nasdaq

Filing Documents

• ef20058828_8k.htm (8-K) — 35KB
• ef20058828_ex99-1.htm (EX-99.1) — 431KB
• ef20058828_ex99-2.htm (EX-99.2) — 18KB
• image00001.jpg (GRAPHIC) — 1KB
• image00003.jpg (GRAPHIC) — 1KB
• 0001140361-25-041802.txt ( ) — 647KB
• vero-20251110.xsd (EX-101.SCH) — 4KB
• vero-20251110_lab.xml (EX-101.LAB) — 21KB
• vero-20251110_pre.xml (EX-101.PRE) — 16KB
• ef20058828_8k_htm.xml (XML) — 4KB

02

Item 2.02. Results of Operations and Financial Condition. On November 13, 2025, Venus Concept Inc. issued a press release relating to its financial results for the three and nine months ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01

Item 8.01. Other Events. On November 10, 2025, the Company issued a press release relating to its receipt of 510(k) clearance from the U.S. Food and Drug Administration (the "FDA") to market the Venus Nova, the Company's new multi-application platform for non-invasive body and skin Treatments. A copy of the press release regarding the above-described FDA clearance is attached as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference. Cautionary Statement Regarding Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements contained herein that are not of historical facts may be deemed to be forward-looking statements. In some cases, you can identify these statements by words such as such as "anticipates," "believes," "plans," "expects," "projects," "future," "intends," "may," "should," "could," "estimates," "predicts," "potential," "continue," "guidance," and other similar expressions that are predictions of or indicate future events and future trends. These forward-looking statements include, but are not limited to, statements about Venus NOVA, the Venus Jumpstart Program and our R&D strategy; statements about our financial performance, metrics and growth; the growth in demand for our new, existing and future systems and other products; the efficacy of our new, existing and future systems and products; the identification and efficacy of strategic alternatives to maximize shareholder value; and the continued implementation of turnaround plans, including debt restructurings and financings. These forward-looking statements are based on current expectations, estimates, forecasts, and projections about our business and the industry in which the Company operates and management's beliefs and assumptions and are not guarantees of future perfo

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibit No. Description 99.1 Pres release dated November 13, 2025 99.2 Press release dated November 10, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VENUS CONCEPT INC. Date: November 13, 2025 By: /s/ Domenic Della Penna Domenic Della Penna Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR